Literature DB >> 12455033

Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis.

Qian An1, Manuela Pacyna-Gengelbach, Karsten Schlüns, Nicole Deutschmann, Suping Guo, Yanning Gao, Jianjun Zhang, Shujun Cheng, Iver Petersen.   

Abstract

Suppression subtractive hybridization (SSH) was applied to identify differentially expressed genes in the SV40LT immortalized human bronchial epithelial cell line Y-BE, with normal human bronchial epithelial cells (HBEC) as a control. Two cDNA libraries of up- and downregulated genes were generated, comprising 218 known genes and 131 unknown genes in total. The expression of 22 clones from the 2 libraries was investigated by Northern blot analysis, and 86.4% (19/22) of them showed differential expression between Y-BE cells and HBEC. Although the Y-BE cells are nontumorigenic in nude mice, Comparative genomic hybridization (CGH) detected some DNA imbalances in Y-BE cells that were similar to lung cancer cells. Our data demonstrate that the studied cell line Y-BE and SSH is a reliable approach for identifying new genes that are associated with immortalization and early tumor development that may help to understand the pathogenesis of lung cancer. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12455033     DOI: 10.1002/ijc.10807

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Identification of differently expressed genes in human colorectal adenocarcinoma.

Authors:  Yao Chen; Yi-Zeng Zhang; Zong-Guang Zhou; Gang Wang; Zeng-Ni Yi
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

2.  Defining a candidate lung cancer gene.

Authors:  Frederic J Kaye
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

3.  RNA helicase DHX9 may be a therapeutic target in lung cancer and inhibited by enoxacin.

Authors:  Shiguang Cao; Ruiying Sun; Wei Wang; Xia Meng; Yuping Zhang; Na Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Rap2B promotes cell proliferation, migration and invasion in prostate cancer.

Authors:  Jiehui Di; Huan Cao; Juangjuan Tang; Zheng Lu; Keyu Gao; Zhesi Zhu; Junnian Zheng
Journal:  Med Oncol       Date:  2016-05-06       Impact factor: 3.064

5.  Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis.

Authors:  Run Tong; Lin Feng; Lei Zhang; Jianzhi Zhang; Yousheng Mao; Kaitai Zhang; Yanning Gao; Guiqi Wang; Shujun Cheng
Journal:  J Interferon Cytokine Res       Date:  2015-08-26       Impact factor: 2.607

6.  Structure, functional regulation and signaling properties of Rap2B.

Authors:  Debao Qu; Hui Huang; Jiehui DI; Keyu Gao; Zheng Lu; Junnian Zheng
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

7.  Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis.

Authors:  Jingsong Yuan; Jinfang Ma; Hongwei Zheng; Taiping Shi; Wenyue Sun; Qiao Zhang; Dongmei Lin; Kaitai Zhang; Jie He; Yousheng Mao; Xia Gao; Peng Gao; Naijun Han; Guobin Fu; Ting Xiao; Yanning Gao; Dalong Ma; Shujun Cheng
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

8.  Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway.

Authors:  Jiehui Di; Hui Huang; Debao Qu; Juangjuan Tang; Wenjia Cao; Zheng Lu; Qian Cheng; Jing Yang; Jin Bai; Yanping Zhang; Junnian Zheng
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

9.  TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.

Authors:  J Wang; J Ou; Y Guo; T Dai; X Li; J Liu; M Xia; L Liu; M He
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

10.  TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis.

Authors:  Fang Liu; Yuan He; Qinghua Cao; Ni Liu; Wenhui Zhang
Journal:  Dis Markers       Date:  2016-09-08       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.